| Dwarakraj Soundarraj, MD | |
|
2521 Glenn Hendren Dr, Suite 306, Liberty, MO 64068-3388 | |
| (816) 407-5490 | |
| (816) 407-5435 |
| Full Name | Dwarakraj Soundarraj |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 29 Years |
| Location | 2521 Glenn Hendren Dr, Liberty, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609079938 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 2011040569 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New Liberty Hospital District | Liberty, MO | Hospital |
| Harrison County Community Hospital | Bethany, MO | Hospital |
| Cameron Regional Medical Center | Cameron, MO | Hospital |
| Hedrick Medical Center | Chillicothe, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New Liberty Hospital Corporation | 9931166618 | 95 |
News Archive
ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics, announced today it has entered into a collaboration in which Cephalon Australia (a wholly owned subsidiary of Cephalon, Inc.) will apply ImmunGene's interferon payload technology to up to six of its new drug targets for cancers.
Living cells inside the body could be placed under surveillance-their location and migration noninvasively tracked in real time over many days-using a new method developed by researchers at KAUST.
Diminished expression, a core negative symptom in people with schizophrenia, is significantly correlated with an array of cognitive functions, research by a Hong Kong team shows.
A new discovery of a potential biomarker for Huntington's disease (HD) could mean a more effective way of evaluating the effectiveness of treatments for this neurological disease.
› Verified 3 days ago
| Entity Name | New Liberty Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669734661 PECOS PAC ID: 9931166618 Enrollment ID: O20120918000321 |
News Archive
ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics, announced today it has entered into a collaboration in which Cephalon Australia (a wholly owned subsidiary of Cephalon, Inc.) will apply ImmunGene's interferon payload technology to up to six of its new drug targets for cancers.
Living cells inside the body could be placed under surveillance-their location and migration noninvasively tracked in real time over many days-using a new method developed by researchers at KAUST.
Diminished expression, a core negative symptom in people with schizophrenia, is significantly correlated with an array of cognitive functions, research by a Hong Kong team shows.
A new discovery of a potential biomarker for Huntington's disease (HD) could mean a more effective way of evaluating the effectiveness of treatments for this neurological disease.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dwarakraj Soundarraj, MD Po Box 219672, Kansas City, MO 64121-9672 Ph: (816) 407-5430 | Dwarakraj Soundarraj, MD 2521 Glenn Hendren Dr, Suite 306, Liberty, MO 64068-3388 Ph: (816) 407-5490 |
News Archive
ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics, announced today it has entered into a collaboration in which Cephalon Australia (a wholly owned subsidiary of Cephalon, Inc.) will apply ImmunGene's interferon payload technology to up to six of its new drug targets for cancers.
Living cells inside the body could be placed under surveillance-their location and migration noninvasively tracked in real time over many days-using a new method developed by researchers at KAUST.
Diminished expression, a core negative symptom in people with schizophrenia, is significantly correlated with an array of cognitive functions, research by a Hong Kong team shows.
A new discovery of a potential biomarker for Huntington's disease (HD) could mean a more effective way of evaluating the effectiveness of treatments for this neurological disease.
› Verified 3 days ago
Julie Anne Marx, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2525 Glenn Hendren Dr, Liberty, MO 64068 Phone: 816-781-7200 Fax: 816-781-6973 | |
Dr. Jonathan Philip Horwitz, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2521 Glenn Hendren Dr, Liberty, MO 64068 Phone: 816-478-4887 Fax: 816-478-7140 | |
Dr. William T Boulware, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1131 W Kansas St, Liberty, MO 64068 Phone: 816-792-5577 | |
Elizabeth Kay Gerstner, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2609 Glenn Hendren Drive, Liberty, MO 64068 Phone: 816-781-7730 Fax: 816-415-1886 | |
Mr. Demetrios George Maragos, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2521 Glenn Hendren Dr, Suite 306, Liberty, MO 64068 Phone: 816-407-5430 Fax: 816-407-5435 | |
Dr. Terrence W Coleman, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2521 Glenn Hendren Dr Ste 411b, Liberty, MO 64068 Phone: 816-429-6057 Fax: 816-429-5709 | |
Dr. Neal Blakely Anson, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2609 Glenn Hendren Drive, Liberty, MO 64068 Phone: 816-781-7730 Fax: 816-415-1886 |